Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO [NA]
An extension study assessing the safety and tolerability of Ranibizumab in subjects with choroidal neovascularization related to age-related…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration [Phase 2]
Phase 2 trial evaluating intravitreal injections of a small interfering RNA therapy for age-related macular degeneration was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2011-12-05Clinical Trial Update: Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy [Phase 3]
A Phase 3 clinical trial update evaluating serial retinal thickness changes and scotoma size in patients with age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Omega-3-fatty Acids on Age-related Macular [NA]
This completed clinical trial evaluated the effect of omega-3 fatty acids on age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration [Phase 4]
Phase 4 clinical trial evaluating intravitreal bevacizumab for choroidal neovascularization secondary to age-related macular degeneration ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Combination Therapy for Age-Related Macular Degeneration. [Phase 2]
Phase 2 trial update for a combination therapy in age-related macular degeneration shows the study has completed enrollment. The status is l…
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Subretinal Macugen® for Neovascular Age-Related Macular Degeneration [Phase 3]
Update on a Phase 3 trial of Macugen (pegaptanib) delivered subretinally for neovascular age-related macular degeneration; the current statu…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: LOC387715/HTRA1 and the Combined Photodynamic Therapy With Intravitreal Bevacizumab in Polypoidal Choroidal Vasculopathy
This trial evaluates combining verteporfin photodynamic therapy with intravitreal bevacizumab to treat polypoidal choroidal vasculopathy, a …
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean Population [NA]
A completed clinical trial investigated LOC387715/HTRA1 genetic variants in polypoidal choroidal vasculopathy among a Korean population. The…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration [Phase 2]
Phase 2 study evaluating oral everolimus for neovascular age-related macular degeneration was terminated, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Macugen Observational Study
Pfizer's Macugen (pegaptanib) observational study for age-related macular degeneration was terminated, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: Prophylactic Laser Treatment of Drusen Maculopathy [NA]
A completed clinical trial evaluated prophylactic laser treatment for drusen maculopathy in age-related macular degeneration. The snippet do…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Scotoma Reduction in AMD Patients Treated With Ranibizumab [Phase 1, Phase 2]
Phase 1/2 trial update reporting scotoma reduction in patients with age-related macular degeneration treated with ranibizumab.
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration [Phase 2]
Phase 2 clinical trial evaluating OT-551 antioxidant eye drops for geographic atrophy in age-related macular degeneration completed with res…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration [Phase 2]
A Phase 2 trial evaluating the combination of ranibizumab and bromfenac for neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab [Phase 2]
Phase 2 clinical trial evaluating ocular growth factors in proliferative retinopathies before and after intravitreal bevacizumab has complet…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration
This clinical trial update covers the evaluation of rheohemapheresis and lutein supplementation for non-exudative age-related macular degene…
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration [Phase 1, Phase 2]
A terminated Phase 1/2 study evaluating the safety and efficacy of AG-013,958 for subfoveal choroidal neovascularization due to age-related …
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization [NA]
A completed clinical trial update investigating aqueous VEGF levels in type 3 neovascularization associated with age-related macular degener…
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration [Phase 2]
Pfizer-sponsored Phase 2 trial of pegaptanib sodium (Macugen) for wet age-related macular degeneration has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib [Phase 3]
A Phase 3 trial comparing verteporfin PDT plus intravitreal triamcinolone versus verteporfin PDT plus intravitreal pegaptanib for age-relate…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Phase 3]
Phase 3 trial evaluating verteporfin photodynamic therapy added to ranibizumab versus ranibizumab alone for subfoveal choroidal neovasculari…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration [Phase 2]
A Phase 2 clinical trial evaluated infliximab, sirolimus, and daclizumab for age-related macular degeneration, with results posted after com…
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: Alprostadil in Maculopathy Study (AIMS) [Phase 3]
Phase 3 trial of alprostadil for macular degeneration was terminated; results were posted on 2011-04-11.
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration [NA]
This clinical trial update reports on changes in retinal function after intravitreal ranibizumab injections for age-related macular degenera…